APELLIS PHARMACEUTICALS INC (APLS) Institutional Ownership Changes & 13F Activity
APELLIS PHARMACEUTICALS INC (APLS). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC and Viking Global Investors.
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q1 2026 | Renaissance Technologies LLC | Buy | 302,900 | 935,958 | $37,653,590 |
| Q4 2025 | Renaissance Technologies LLC | Sell | -89,837 | 633,058 | $15,902,417 |
| Q3 2025 | Renaissance Technologies LLC | Buy | 711,907 | 722,895 | $16,359,114 |
| Q2 2025 | Renaissance Technologies LLC | Sell | -260,925 | 10,988 | $190,202 |
| Q4 2024 | Renaissance Technologies LLC | Sell | -100,418 | 271,913 | $8,676,744 |
| Q3 2024 | Renaissance Technologies LLC | Buy | 233,818 | 372,331 | $10,738,026 |
| Q2 2023 | Renaissance Technologies LLC | Sell | -48,900 | 138,513 | $12,619 |
| Q4 2022 | Renaissance Technologies LLC | Sell | -157,700 | 187,413 | $9,691 |
| Q3 2022 | Viking Global Investors | Buy | 932,441 | 932,441 | $63,686 |
| Q3 2022 | Renaissance Technologies LLC | Buy | 324,902 | 345,113 | $23,571 |
| Q2 2021 | Renaissance Technologies LLC | Sell | -353,302 | 20,211 | $1,277 |
| Q1 2021 | Renaissance Technologies LLC | Buy | 157,200 | 373,513 | $16,027 |
| Q4 2020 | Renaissance Technologies LLC | Buy | 196,800 | 216,313 | $12,373 |
| Q4 2019 | Renaissance Technologies LLC | Sell | -6,687 | 19,513 | $597 |
| Q1 2019 | Renaissance Technologies LLC | Buy | 26,200 | 26,200 | $511 |
Frequently asked questions about APLS activity
Which institutional owners are buying APLS?
Institutional owners buying APLS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in APLS activity?
"Buy" means an investor increased their reported position in APLS compared to the prior reporting period. This reflects growing exposure to APELLIS PHARMACEUTICALS INC (APLS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in APLS increasing?
Institutional interest in APLS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related APLS Institutional Insights
- APLS Institutional Ownership Overview
- APLS Institutional Ownership & Insiders Activity
- APLS Institutional Ownership & 13F Activity
- APLS Top Institutional Shareholders
- APLS Institutional Buying Activity
- APLS Institutional Selling Activity
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- APLS Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings